Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Hey PTSC BOD take a lesson from TAUG CEO...

Tauriga Sciences Inc. Chief Executive Officer Reports Additional Insider Purchases "Open Market" Exceeding 3,500,000 Shares Since August 01, 2013.

NEW YORK, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (TAUG) ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and evaluating potentially lucrative acquisition targets in an industry agnostic manner, has today announced that its Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has completed an additional series of insider purchases (open market) that have exceeded 3,500,000 shares since August 01, 2013. These shares have been purchased at a price range between $0.0175 and $0.03 per share, with corresponding Form 4(s) having been filed at the appropriate times to disclose the insider purchases.

Commenting on the most recent additional insider purchases, Tauriga's CEO Seth M. Shaw stated, "The Company has vastly improved its business prospects and I have great confidence in the abilities of the management team and board of directors to create shareholder value. With the recent completion of the license agreement with Green Hygienics, Inc. and the intriguing acquisition opportunities currently being contemplated by the board of directors, I believe that the company once again has a bright future. Should the company continue to experience significant pressure on its share price, I am prepared to continue or even accelerate my insider purchases due to my strong belief in this organization's future."

Share
New Message
Please login to post a reply